Financial Results

Latest Financial Results

Filter

Period

Filter by

recent search

Showing: 105 of 25 Financial Results

Ipsen presents its half year 2020 results and reinstates guidance for full year 2020
Ipsen presents its half year 2020 results and reinstates guidance for full year 2020

David Loew, Chief Executive Officer of Ipsen, stated: “I’m honored since July 1st to lead Ipsen, an exciting global biopharma business with solid business fundamentals, a strong purpose to serve patients and attractive growth opportunities. I am encouraged by the exceptional levels…


Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact
Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact

Paris (France), 22 April 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its sales for the first quarter of 2020.


Ipsen presents its 2019 results, provides 2020 guidance and updates 2022 financial outlook
Ipsen presents its 2019 results, provides 2020 guidance and updates 2022 financial outlook

Aymeric Le Chatelier, Chief Executive Officer and Chief Financial Officer of Ipsen, stated: “2019 was another excellent year of operating performance for Ipsen with continued double-digit top-line growth and core operating margin expansion. Despite the recent palovarotene setback, the fundamentals of…




Your dedicated contacts